Ondine Biomedical Inc.
OBI.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£19,098 | -£14,412 | -£19,372 | -£50,085 |
| Dep. & Amort. | £565 | £587 | £493 | £514 |
| Deferred Tax | £0 | £0 | £0 | £31,622 |
| Stock-Based Comp. | £1,216 | £640 | £1,445 | £4,063 |
| Change in WC | £1,913 | -£298 | £102 | £131 |
| Other Non-Cash | -£86 | -£170 | £987 | £1,215 |
| Operating Cash Flow | -£15,490 | -£13,653 | -£16,345 | -£12,540 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£10 | -£177 | -£311 | -£77 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | £0 |
| Investing Cash Flow | -£10 | -£177 | -£311 | -£77 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £1,117 | -£40 | £0 | £6,399 |
| Stock Issued | £22,980 | £4,912 | £0 | £37,727 |
| Stock Repurch. | £0 | £0 | £0 | -£799 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£2,360 | -£1,087 | -£275 | -£1,423 |
| Financing Cash Flow | £21,737 | £3,785 | -£275 | £41,904 |
| Forex Effect | £551 | -£89 | £335 | -£45 |
| Net Chg. in Cash | £6,788 | -£10,134 | -£16,596 | £29,242 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £3,138 | £13,272 | £29,868 | £626 |
| End Cash | £9,926 | £3,138 | £13,272 | £29,868 |
| Free Cash Flow | -£15,500 | -£13,830 | -£16,656 | -£12,617 |